REAL-WORLD ANALYSIS OF PHARMACOUTILIZATION AND OUTCOMES OF PATIENTS ON PERINDOPRIL/AMLODIPINE/INDAPAMIDE FREE VS SINGLE-PILL COMBINATION IN ITALY

被引：0
|
作者：
Borghi, Claudio [1 ]
Jayagopal, Pathiyil Balagopalan [2 ]
Konradi, Alexandra [3 ]
Aparecido Bortolotto, Luiz [4 ]
Esposti, Luca Degli [5 ]
Perrone, Valentina [5 ]
Snyman, Jacques R. [6 ]
机构：
[1] Univ Bologna, Bologna, Italy
[2] Lakshmi Hosp, Palakkad, India
[3] Almazov Natl Med Res Ctr, Moscow, Russia
[4] Hosp Clin FMUSP, Sao Paulo, Brazil
[5] CliCon Srl, Soc Benefit Hlth, Econ & Outcomes Res, Bologna, Italy
[6] Forte Res Pty Ltd, Gauteng, South Africa
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PS-BPC07-5
引用
收藏
页码：E310 / E310
页数：1
相关论文
共 50 条
  • [1] A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy
    Snyman, Jacques R.
    Bortolotto, Luiz Aparecido
    Esposti, Luca Degli
    Jayagopal, Pathiyil Balagopalan
    Konradi, Alexandra O.
    Perrone, Valentina
    Borghi, Claudio
    [J]. JOURNAL OF HYPERTENSION, 2024, 42 (01) : 136 - 142
  • [2] Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy
    Borghi, Claudio
    Jayagopal, Pathiyil Balagopalan
    Konradi, Alexandra
    Bortolotto, Luiz Aparecido
    Degli Esposti, Luca
    Perrone, Valentina
    Snyman, Jacques R.
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1765 - 1772
  • [3] Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy
    Claudio Borghi
    Pathiyil Balagopalan Jayagopal
    Alexandra Konradi
    Luiz Aparecido Bortolotto
    Luca Degli Esposti
    Valentina Perrone
    Jacques R. Snyman
    [J]. Advances in Therapy, 2023, 40 (4) : 1765 - 1772
  • [4] DO TRIPLE SINGLE-PILL COMBINATIONS MAKE A DIFFERENCE IN TREATMENT ADHERENCE, OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION IN HYPERTENSION? A REAL-WORLD ANALYSIS OF PATIENTS ON PERINDOPRIL/AMLODIPINE/INDAPAMIDE IN ITALY
    Snyman, J.
    Jayagopal, Balagopalan R.
    Konradi, A.
    Bortolotto, L. A.
    Degli Esposti, L.
    Perrone, V
    Borghi, C.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S149 - S149
  • [5] Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension
    Wang, J.
    Bricout, S.
    Zhu, H.
    Li, X.
    Zhang, X.
    Sun, Y.
    Zhao, X.
    Li, Z.
    Zhao, R.
    Sun, Y.
    Yao, Z.
    Li, H.
    Lu, W.
    Jiang, Y.
    Han, Q.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [6] Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial
    Nedogoda S.V.
    Stojanov V.J.
    [J]. Cardiology and Therapy, 2017, 6 (1) : 91 - 104
  • [7] SINGLE-PILL TRIPLE COMBINATION OF PERINDOPRIL/INDAPAMIDE/AMLODIPINE IN PATIENTS WITH ESSENTIAL HYPERTENSION: SERBIAN EXPERIENCE
    Tasic, Nebojsa
    Tasic, Danijela
    Balevic, Milijana
    Dragisic, Dalibor
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E445 - E445
  • [8] REAL-WORLD ANALYSIS OF ADHERENCE, OUTCOMES AND HEALTHCARE COSTS OF THE QUADRUPLE COMBINATION PERINDOPRIL, INDAPAMIDE, AMLODIPINE AND BISOPROLOL IN ITALY
    Mancia, Giuseppe
    Brouwers, Sofie
    Desideri, Giovambattista
    Esposti, Luca Degli
    Perrone, Valentina
    Narkiewicz, Krzysztof
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E483 - E483
  • [9] Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension
    Tsioufis, Kostas
    Douma, Stella
    Kallistratos, Manolis S.
    Manolis, Athanasios J.
    [J]. CLINICAL DRUG INVESTIGATION, 2019, 39 (04) : 385 - 393
  • [10] Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension
    Kostas Tsioufis
    Stella Douma
    Manolis S. Kallistratos
    Athanasios J. Manolis
    [J]. Clinical Drug Investigation, 2019, 39 : 385 - 393
12345